Previous 10 | Next 10 |
home / stock / ebs / ebs articles
Emergent BioSolutions, Inc. (NYSE:EBS) shares are trading lower in the premarket session on Thursday after ending yesterday’s run with a ...
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-qu...
Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company's debt GAIT...
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global company providing solutions that address public ...
Emergent Biosolutions Inc (NYSE: EBS) shares initially traded higher Tuesday before pulling back and turning negative. The company received a ...
Third Quarter 2023 Total Revenues of $271M, above the prior guidance range Third Quarter 2023 Pre-Tax Loss of $(266)M and Adjusted EBITDA(2) of...
GAITHERSBURG, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) has rescheduled its conference call to Wednesday, Nov...
GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Do...
Walgreens Boots Alliance Inc (NASDAQ: WBA) said over-the-counter (OTC) NARCAN Nasal Spray will be available at Walgreens stores and ...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human S...
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human S...